Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients

doi:10.3748/wjg.v19.i9.1387

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5574)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

333

HTML

3178

Figures (1-6)

162

Tables (1-4)

133

Sum=3806

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1039

Download

729

Sum=1768

Mar 7, 2013 (publication date) through Jul 24, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 7, 2013; 19(9): 1387-1395
Published online Mar 7, 2013. doi: 10.3748/wjg.v19.i9.1387

Table 2 Clinical and laboratory data according to rs1127354 inosine triphosphate pyrophosphatase genotypes (mean ± SD)

Criteria	CC	CA + AA	P value
Number, n (%)	93 (91.2)	9 (8.8)
Age (yr)	32.3 ± 7.3	34.4 ± 7.7	0.457
Sex (male/female)	82/11	8/1
BMI	25.4 ± 2.8	26.8 ± 1.6	0.046
Baseline Hb (g/dL)	14 ± 1.2	14.3 ± 1.03	0.441
plt (× 10³/μL)	233.2 ± 62.1	292.2 ± 74.3	0.046
WBCs (× 10³/μL)	6.2 ± 1.5	6.8 ± 1.1	0.172
ALT > ULN, n (%)	71 (76.3)	7 (77.7)	> 0.99
Creatinine level (mg/dL)	0.9 ± 0.46	0.98 ± 0.22	0.349
Baseline HCV RNA (log IU/mL)	5.46 ± 0.7	5.4 ± 0.8	> 0.99

Hb: Hemoglobin; BMI: Body mass index; plt: Platelet; WBCs: White blood cells; ALT: Alanine aminotransferase; ULN: Upper limit of normal of ALT = 12 IU/L; HCV: Hepatitis C virus.

Citation: Ahmed WH, Furusyo N, Zaky S, Sharaf Eldin A, Aboalam H, Ogawa E, Murata M, Hayashi J. Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients. World J Gastroenterol 2013; 19(9): 1387-1395
URL: https://www.wjgnet.com/1007-9327/full/v19/i9/1387.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i9.1387